<SEC-DOCUMENT>0001370053-22-000031.txt : 20220504
<SEC-HEADER>0001370053-22-000031.hdr.sgml : 20220504
<ACCEPTANCE-DATETIME>20220504161920
ACCESSION NUMBER:		0001370053-22-000031
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220504
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220504
DATE AS OF CHANGE:		20220504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANAPTYSBIO, INC
		CENTRAL INDEX KEY:			0001370053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				203828755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37985
		FILM NUMBER:		22891778

	BUSINESS ADDRESS:	
		STREET 1:		10770 WATERIDGE CIRCLE, SUITE 210
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-362-6295

	MAIL ADDRESS:	
		STREET 1:		10770 WATERIDGE CIRCLE, SUITE 210
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANAPTYSBIO INC
		DATE OF NAME CHANGE:	20080828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANAPTYS BIOSCIENCES INC
		DATE OF NAME CHANGE:	20060724
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>anab-20220504.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:6d9c16b3-a589-4aec-89ca-e384d48b998d,g:32b768c6-7c8a-4df9-9800-0b893d28d3c0,d:74d21cd0fbcd40aeb9b904c8781a809a--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>anab-20220504</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV80L2ZyYWc6ZTg3NmQ4NTU2ODdkNDcyMDkwZDcxZjYxY2Y4Njk5Y2UvdGFibGU6NGM4YTgyNjZkMTMyNDA4ZGE5NTU3MjI4MzhiNGFlMmMvdGFibGVyYW5nZTo0YzhhODI2NmQxMzI0MDhkYTk1NTcyMjgzOGI0YWUyY18yLTEtMS0xLTM1OTQ5_afd22cf3-ad3f-4b3b-b8ee-ef90cda645b6">0001370053</ix:nonNumeric><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV80L2ZyYWc6ZTg3NmQ4NTU2ODdkNDcyMDkwZDcxZjYxY2Y4Njk5Y2UvdGFibGU6NGM4YTgyNjZkMTMyNDA4ZGE5NTU3MjI4MzhiNGFlMmMvdGFibGVyYW5nZTo0YzhhODI2NmQxMzI0MDhkYTk1NTcyMjgzOGI0YWUyY181LTEtMS0xLTM1OTQ5_6fd97710-5317-4a0b-9378-824dd9e66860">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="anab-20220504.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001370053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-04</xbrli:startDate><xbrli:endDate>2022-05-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i74d21cd0fbcd40aeb9b904c8781a809a_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY4_1bb7ceb0-f796-422e-a780-9299a1d85251">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report: <ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xOTE_bb9275fd-aa25-439e-a7cf-ad34b17dd4d3">May 4, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcy_4eeff25d-3b12-4deb-868f-caba772444e9">ANAPTYSBIO, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.857%"><tr><td style="width:1.0%"></td><td style="width:33.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6YTczNWRjNWEzNzU0NGU5Zjg4MWI3NjJjM2I0ZWE4NGUvdGFibGVyYW5nZTphNzM1ZGM1YTM3NTQ0ZTlmODgxYjc2MmMzYjRlYTg0ZV8wLTAtMS0xLTM1OTQ5_e9e05957-dd2f-4f6c-b0e0-c6618c20a940">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6YTczNWRjNWEzNzU0NGU5Zjg4MWI3NjJjM2I0ZWE4NGUvdGFibGVyYW5nZTphNzM1ZGM1YTM3NTQ0ZTlmODgxYjc2MmMzYjRlYTg0ZV8wLTEtMS0xLTM1OTQ5_43e7e4e4-a598-4bea-8810-8bb9bff4c865">001-37985</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6YTczNWRjNWEzNzU0NGU5Zjg4MWI3NjJjM2I0ZWE4NGUvdGFibGVyYW5nZTphNzM1ZGM1YTM3NTQ0ZTlmODgxYjc2MmMzYjRlYTg0ZV8wLTItMS0xLTM1OTQ5_a576013f-c5c7-4385-9512-aadbc20e0409">20-3828755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcz_0dfee24b-7f04-4ffd-9995-e22cc8c511c7">10770 Wateridge Circle</ix:nonNumeric>, <ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzYz_2f3a8ca4-5293-49e5-942b-c14635aac315">Suite 210,</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY5_80797694-da38-4665-a82a-8c2f955bf847">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzU4_38833837-9432-43b4-ae14-143bed20f4b5">CA</ix:nonNumeric>  <ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcw_a28e25e6-a905-4e71-bfd5-5a0df9b555a4">92121</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, and Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcx_3aab910d-5e2c-4eb6-a520-35730e1fbe3f">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzU5_79e1a37e-6ac0-4774-8261-ab995f03d47f">362-6295</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY0_bc0907ad-13c8-4430-a8ba-4d92770151d9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communication pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzYx_3ef076ce-d39b-4a76-a3ea-9563edbb38d1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzYy_45f8b98b-1621-4942-afdf-9b05e188a7b1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY1_9297f29c-7910-430a-b680-38496ae4aefa">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.866%"><tr><td style="width:1.0%"></td><td style="width:35.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6NDU4NTM4MjExZGNhNDA3ZTg4OGVlYTY2MzQ1NDhhOTQvdGFibGVyYW5nZTo0NTg1MzgyMTFkY2E0MDdlODg4ZWVhNjYzNDU0OGE5NF8xLTAtMS0xLTM1OTQ5_fb2e5091-1af4-490f-9a0f-ae89d9c552a3">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6NDU4NTM4MjExZGNhNDA3ZTg4OGVlYTY2MzQ1NDhhOTQvdGFibGVyYW5nZTo0NTg1MzgyMTFkY2E0MDdlODg4ZWVhNjYzNDU0OGE5NF8xLTEtMS0xLTM1OTQ5_35c3508d-d5e8-4fc1-b116-9d8ac2f29d62">ANAB</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6NDU4NTM4MjExZGNhNDA3ZTg4OGVlYTY2MzQ1NDhhOTQvdGFibGVyYW5nZTo0NTg1MzgyMTFkY2E0MDdlODg4ZWVhNjYzNDU0OGE5NF8xLTItMS0xLTM1OTQ5_ac5ed5ee-43a4-412f-a287-ff6615d1a36a">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY2_5d0800a5-7f56-4694-a095-df11dc4afb1e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i74d21cd0fbcd40aeb9b904c8781a809a_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item&#160;2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">On May 4, 2022, AnaptysBio, Inc. (&#8220;AnaptysBio&#8221;) issued a press release announcing its financial results for the three months ended March 31, 2022. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The information in this Item 2.02, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed by AnaptysBio with the Securities and Exchange Commission, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in such filing (or any reference to this Current Report on Form 8-K generally), except as shall be expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item 9.01. &#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d) Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.106%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Exhibit Title or Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline" href="q12022earningsrelease.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Press release issued by AnaptysBio, Inc. regarding its financial results for the three months ended March 31, 2022, dated May 4, 2022.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AnaptysBio, Inc.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  May 4, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/Dennis Mulroy</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name: Dennis Mulroy</span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title: Chief Financial Officer</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q12022earningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic2dd8ff01b3641068f820faff819e7d1_1"></div><div style="min-height:42.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:161%">AnaptysBio Announces First Quarter 2022 Financial Results and </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Provides Pipeline Update</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Top-line data from the ongoing imsidolimab (anti-IL-36R Ab) HARP Phase 2 trial in moderate-to-severe hidradenitis suppurativa is anticipated in Q3 2022</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Top-line data from the ongoing imsidolimab GEMINI-1 Phase 3 trial in GPP is anticipated in Q4 2023</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Top-line data from the ongoing rosnilimab (anti-PD-1 agonist Ab) AZURE Phase 2 trial in moderate-to-severe alopecia areata is anticipated in H1 2023</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Ended Q1 2022 with approximately $596.8 million in cash with anticipated 2022 net cash burn of $90 to $100 million</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SAN DIEGO, May 4, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> - AnaptysBio, Inc. (Nasdaq&#58; ANAB), a clinical-stage biotechnology company developing first-in-class antibodies focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today reported operating results for the first quarter ended March 31, 2022 and provided pipeline updates.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We are excited with our recently released Phase 1 trial results of ANB032, our anti-BTLA agonist, and the potential to broadly treat T and B-cell driven inflammatory diseases. Our recently initiated strategic portfolio review will define the path forward across a breadth of clinical development options of potential inflammation-focused indications that could be pursued for each of our clinical and preclinical therapeutic antibody programs,&#8221; said Daniel Faga, interim president and chief executive officer of AnaptysBio. &#8220;We look forward to continuing to execute on our ongoing clinical trials with multiple readouts throughout the next 18 months.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Imsidolimab (Anti-IL-36 receptor) Program</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Imsidolimab, our investigational wholly owned anti-IL-36R therapeutic antibody, is in Phase 3 trials in generalized pustular psoriasis (GPP), and we anticipate top-line data from the GEMINI-1 Phase 3 clinical trial in Q4 2023.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">We anticipate top-line data from the HARP Phase 2 trial in moderate-to-severe hidradenitis suppurativa in Q3 2022.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rosnilimab (Anti-PD-1 agonist) Program</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Rosnilimab, our investigational wholly owned anti-PD-1 agonist therapeutic antibody, previously known as ANB030, is in the AZURE Phase 2 clinical trial in moderate-to-severe alopecia areata, and we anticipate top-line data in H1 2023.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ANB032 (Anti-BTLA agonist) Program</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Announced positive top-line phase 1 data in April 2022 of ANB032, our investigational wholly owned anti-BTLA agonist antibody, demonstrating favorable safety and tolerability with no dose limiting toxicities were observed and no serious adverse events (SAEs) reported.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">ANB032 pharmacokinetic analyses demonstrated a favorable profile including an approximate two-week half-life and Full BTLA receptor occupancy rapidly within hours and was maintained for greater than 30 days.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">ANB032 also demonstrated rapid and sustained target engagement on both T cells and B cells.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">We are advancing ANB032 with an IND filing for a Phase 2 clinical trial anticipated in H2 2022.</font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">First Quarter Financial Results</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Cash, cash equivalents and investments totaled $596.8 million as of March&#160;31, 2022, compared to $615.2 million as of December&#160;31, 2021, for a decrease of $18.4 million. The decrease relates primarily to cash used for operating activities offset by cash received from stock option exercises.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Collaboration revenue was $1.0 million for the three months ended March 31, 2022, compared to $11.2 million for the three months ended March 31, 2021. The decrease relates primarily to one milestone achieved for JEMPERLI in the first quarter of 2021 for $10.0 million, and no milestones achieved in the first quarter of 2022.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Research and development expenses were $22.5 million for the three months ended March 31, 2022, compared to $24.2 million for the three months ended March 31, 2021. The decrease was due primarily to reduced imsidolimab manufacturing costs offset by increased costs for the Company&#8217;s clinical programs. The R&#38;D non-cash, stock-based compensation expense was $1.7 million for the three months ended March 31, 2022 as compared to $1.2 million in the same period in 2021.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">General and administrative expenses were $10.2 million for the three months ended March 31, 2022, compared to $5.4 million for the three months ended March 31, 2021. The increase was due primarily to $3.8 million of costs incurred for our former President and CEO&#8217;s resignation in the first quarter of 2022. The G&#38;A non-cash, stock-based compensation expense was $6.1 million for the three months ended March 31, 2022 which includes $3.2 million of the $3.8 million one-time costs described earlier as compared to $2.1 million in the same period in 2021.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Net loss was $36.3 million for the three months ended March 31, 2022, or a net loss per share of $1.31, compared to a net loss of $18.2 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the three months ended March 31, 2021, or a net loss per share of $0.66.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About AnaptysBio</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AnaptysBio&#160;is a clinical-stage biotechnology company developing first-in-class antibodies focused on unmet medical needs in inflammation. The Company&#8217;s proprietary anti-inflammatory pipeline includes imsidolimab, its anti-IL-36R antibody, previously referred to as ANB019, for the treatment of dermatological inflammatory diseases, including generalized pustular psoriasis, or GPP, and moderate-to-severe hidradenitis suppurativa&#59; rosnilimab, its anti-PD-1 agonist program, previously referred to as ANB030, for the treatment of moderate-to-severe alopecia areata&#59; and its anti-BTLA agonist program, ANB032, which is broadly applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. AnaptysBio&#8217;s antibody pipeline has been developed using its proprietary somatic hypermutation, or SHM platform, which uses </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">in vitro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> SHM for antibody discovery and is designed to replicate key features of the human immune system to overcome the limitations of competing antibody discovery technologies.&#160;AnaptysBio&#160;has also developed multiple therapeutic antibodies in an immuno-oncology collaboration with GSK, including an anti-PD-1 antagonist antibody (JEMPERLI (dostarlimab-gxly) GSK4057190), an anti-TIM-3 antagonist antibody (cobolimab, GSK4069889) and an anti-LAG-3 antagonist antibody (GSK4074386).</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of the &#34;safe harbor&#34; provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to&#58; the timing of the release of data from our clinical trials, including imsidolimab&#8217;s Phase 3 clinical trial in GPP, Phase 2 clinical trial in hidradenitis suppurativa, and rosnilimab&#8217;s Phase 2 clinical trial in alopecia areata&#59; and the timing of ANB032&#8217;s IND filing for a Phase 2 clinical trial&#59; and our projected use of our cash resources. Statements including words such as &#8220;plan,&#8221; &#8220;continue,&#8221; &#8220;expect,&#8221; or &#8220;ongoing&#8221; and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements are subject to risks and uncertainties that may cause the company&#8217;s actual activities or results to differ significantly from those expressed in any forward-looking statement, including risks and uncertainties related to the company&#8217;s ability to advance its product candidates, obtain regulatory approval of and ultimately commercialize its product candidates, the timing and results of preclinical and </font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">clinical trials, the company&#8217;s ability to fund development activities and achieve development goals, the company&#8217;s ability to protect intellectual property and other risks and uncertainties described under the heading &#8220;Risk Factors&#8221; in documents the company files from time to time with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:161%">Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Dennis Mulroy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">AnaptysBio, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">858.732.0201</font></div><div><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:161%;text-decoration:underline">dmulroy&#64;anaptysbio.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:161%"> </font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">AnaptysBio, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">Consolidated Balance Sheets </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">(in thousands, except par value data)</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(unaudited) </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,412&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,729&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables from collaborative partners</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">921&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">876&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,209&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,368&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,869&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,903&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512,411&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,876&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,162&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,283&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,147&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,195&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,097&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625,171&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643,070&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,481&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,741&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,763&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,853&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liability</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,537&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,505&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,781&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,099&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability related to sale of future royalties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255,584&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,093&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liability, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,059&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,450&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $0.001 par value, 500,000 shares authorized, 28,178 shares and 27,647 shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">691,161&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">678,575&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,434)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(422)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(358,008)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(321,753)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,747&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356,428&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity </font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625,171&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643,070&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">AnaptysBio, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">Consolidated Statements of Operations and Comprehensive Loss</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">(in thousands, except per share data) </font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(unaudited)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.069%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaboration revenue</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">970&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,247&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,516&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,185&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,203&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,423&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,719&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,608&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,749)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,361)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense for the sale of future royalties</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,854)</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense), net</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,506)</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 39.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,255)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,163)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on available for sale securities</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,012)</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,267)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,270)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per common share&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Basic and diluted</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.31)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.66)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average number of shares outstanding&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Basic and diluted</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,713&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,361&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>anab-20220504.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6d9c16b3-a589-4aec-89ca-e384d48b998d,g:32b768c6-7c8a-4df9-9800-0b893d28d3c0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:anab="http://www.anaptysbio.com/20220504" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.anaptysbio.com/20220504">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="anab-20220504_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="anab-20220504_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="anab-20220504_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.anaptysbio.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>anab-20220504_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6d9c16b3-a589-4aec-89ca-e384d48b998d,g:32b768c6-7c8a-4df9-9800-0b893d28d3c0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CoverPage" xlink:type="simple" xlink:href="anab-20220504.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.anaptysbio.com/role/CoverPage" xlink:type="extended" id="i5a5a0d9d9a1c4576846d179bb931947f_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a64b81df-f216-4055-ac17-a2f6255277d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_60c448a6-5571-4833-a433-dce64c2d9072" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a64b81df-f216-4055-ac17-a2f6255277d9" xlink:to="loc_dei_DocumentType_60c448a6-5571-4833-a433-dce64c2d9072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_a64b81df-f216-4055-ac17-a2f6255277d9" xlink:to="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:to="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_655d1335-2862-46d4-9557-0f28aa119f9a_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:to="loc_dei_DocumentDomain_655d1335-2862-46d4-9557-0f28aa119f9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_1ac51e0a-d238-4f50-bd37-640ac4da75d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:to="loc_dei_DocumentDomain_1ac51e0a-d238-4f50-bd37-640ac4da75d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ce47d4c6-fe8e-4c2f-9a3f-9189eec33ca0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressAddressLine1_ce47d4c6-fe8e-4c2f-9a3f-9189eec33ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_4ef1d7d1-c680-42e9-9934-498a89bcd3fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressAddressLine2_4ef1d7d1-c680-42e9-9934-498a89bcd3fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d5781f82-c36b-48c9-bf94-8cb940533f23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressCityOrTown_d5781f82-c36b-48c9-bf94-8cb940533f23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ae098984-7b9e-4ff0-9c02-7aeb03dbc392" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressStateOrProvince_ae098984-7b9e-4ff0-9c02-7aeb03dbc392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6dc18e75-7689-439b-9a17-b17cbce1e1a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressPostalZipCode_6dc18e75-7689-439b-9a17-b17cbce1e1a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_e312e63c-aa6e-48a5-b285-0eb65f852f7e_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:to="loc_dei_AddressTypeDomain_e312e63c-aa6e-48a5-b285-0eb65f852f7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_1fe7855d-541a-4b5a-957a-3429fae924ec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:to="loc_dei_AddressTypeDomain_1fe7855d-541a-4b5a-957a-3429fae924ec" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>anab-20220504_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6d9c16b3-a589-4aec-89ca-e384d48b998d,g:32b768c6-7c8a-4df9-9800-0b893d28d3c0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_2ea84ce9-ccf8-454d-a3a2-2bc55a6fdfaf_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a107d77e-51e8-4db6-91af-fb6abfae1ed5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_54480976-5cef-424c-98aa-8d237901e497_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1df649fc-f229-487d-b1d5-8401bfd377c4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0ff9cfe9-3f8a-4d86-808e-0500f08b603c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_f0d481d6-f4ae-4ab7-8d94-03842c526e13_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_4080a22c-511b-4220-a447-cd1b0e7e36d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_bf450365-827f-47ed-8caf-62a9ff67cfad_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_671442cc-e827-4a40-ae4d-972786df7ff4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_56ade681-b03a-46c9-83d1-1efdc2655d0b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_14799cc7-5ebd-431a-aabd-3d0e4f4810f6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d1816d35-4b22-48bd-9893-ac2340960275_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c2a2cbf9-1fe6-49f5-a9d2-aa26d7adab07_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_c42c0104-8b36-4348-8fcb-7b3394bb5e1b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_41e9fc7e-ae65-458a-b98a-9b77539321e1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_19cf5bad-c601-425e-9f8d-a6d4320b0acf_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_84424c5b-38c3-4211-9d74-ace741fdb703_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesTable_adbcbfc2-429a-4af0-ad6d-17775c9966c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Table]</link:label>
    <link:label id="lab_dei_EntityAddressesTable_label_en-US" xlink:label="lab_dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesTable" xlink:to="lab_dei_EntityAddressesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_29efca32-c8c6-4863-aedd-dd0c0176031d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6accae5f-8c1d-46f1-b94e-9524abe3e2f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_034e6e2b-6e81-4cce-b9c5-8de46db2fb52_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c34a2d38-ee84-4501-9180-b96b8ebff53c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_5358aa1f-04c8-49c0-83e2-252e06b77ed6_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_45341bd7-ebf9-447b-b2b3-752d282b3730_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_41dd3f9c-0fe2-48e5-a00c-3e5b2aaf9741_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_44e04920-f915-422d-8beb-48fc483bbf8e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9da841c7-e83f-4b3a-bf76-bc1ce6b1efbb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_a8bbf9d3-fb26-4cc8-b089-ee0f42ad3d6f_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_51f438f5-2450-4a32-9ed2-65de9add71b2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesLineItems_635f40ee-3676-498c-ad97-03a15c83ce9c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
    <link:label id="lab_dei_EntityAddressesLineItems_label_en-US" xlink:label="lab_dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesLineItems" xlink:to="lab_dei_EntityAddressesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1924d91d-eebf-41d1-93dc-df8f2c8a3e1b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d72935ba-fd16-4774-8274-9e2fdf9c2d85_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>anab-20220504_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6d9c16b3-a589-4aec-89ca-e384d48b998d,g:32b768c6-7c8a-4df9-9800-0b893d28d3c0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CoverPage" xlink:type="simple" xlink:href="anab-20220504.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.anaptysbio.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5f793eba-e004-4305-aeef-39ce0647b20f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_DocumentType_5f793eba-e004-4305-aeef-39ce0647b20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_95ff57e8-965b-4164-ba03-f97205f03756" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_DocumentPeriodEndDate_95ff57e8-965b-4164-ba03-f97205f03756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_661a3726-ff3f-4919-8cfc-4f43a8744e7c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityRegistrantName_661a3726-ff3f-4919-8cfc-4f43a8744e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_79a857dc-9eec-4eee-b5d0-d0a9b949d4ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityIncorporationStateCountryCode_79a857dc-9eec-4eee-b5d0-d0a9b949d4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4cb011ef-67d9-4843-b59a-6060c73fb430" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityFileNumber_4cb011ef-67d9-4843-b59a-6060c73fb430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e1a7a60e-7ce4-42a3-8ef5-b9faf9576b76" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityTaxIdentificationNumber_e1a7a60e-7ce4-42a3-8ef5-b9faf9576b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_197371e3-b8fa-4f64-8e18-046ce41d6c7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityAddressAddressLine1_197371e3-b8fa-4f64-8e18-046ce41d6c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_5e2af12e-6430-4a92-ac35-1115cb121407" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityAddressAddressLine2_5e2af12e-6430-4a92-ac35-1115cb121407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_22f76332-8ae8-43e4-aeb0-1da1395d0b8f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityAddressCityOrTown_22f76332-8ae8-43e4-aeb0-1da1395d0b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3838426b-b9de-4b01-8588-4f615cfc300e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityAddressStateOrProvince_3838426b-b9de-4b01-8588-4f615cfc300e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_30059d70-f75a-4ae6-859f-312e205c943d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityAddressPostalZipCode_30059d70-f75a-4ae6-859f-312e205c943d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_35d77beb-2486-47a9-9381-d7a5be8877d5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_CityAreaCode_35d77beb-2486-47a9-9381-d7a5be8877d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_81c1cd2e-968d-47b6-8d4f-fc5b8c095fc8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_LocalPhoneNumber_81c1cd2e-968d-47b6-8d4f-fc5b8c095fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_802d4b0b-a0d0-4a71-a52f-73d2a5ed48ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_WrittenCommunications_802d4b0b-a0d0-4a71-a52f-73d2a5ed48ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_50c1ec55-fecc-4a20-b626-c39b2c111f63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_SolicitingMaterial_50c1ec55-fecc-4a20-b626-c39b2c111f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_ffaee425-481e-4edf-869c-88c75200809f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_PreCommencementTenderOffer_ffaee425-481e-4edf-869c-88c75200809f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_75f7d1d7-2569-47dc-8533-dd9724808416" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_75f7d1d7-2569-47dc-8533-dd9724808416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_88740b31-d4e3-450e-946b-e8fc4b6d637a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_Security12bTitle_88740b31-d4e3-450e-946b-e8fc4b6d637a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_211d3042-6e49-4b2f-8c74-ba360f6a77a0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_TradingSymbol_211d3042-6e49-4b2f-8c74-ba360f6a77a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f39ffdd3-dbbf-424b-a798-223ef4ebd8c8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_SecurityExchangeName_f39ffdd3-dbbf-424b-a798-223ef4ebd8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2c9f1ae0-cd0a-41da-b986-305f48154b81" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityEmergingGrowthCompany_2c9f1ae0-cd0a-41da-b986-305f48154b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8e2f889b-748f-458e-8568-d79af5c5cfea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityCentralIndexKey_8e2f889b-748f-458e-8568-d79af5c5cfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_65e4ef7a-1a2f-4713-aa9d-4a1652c6d4e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_AmendmentFlag_65e4ef7a-1a2f-4713-aa9d-4a1652c6d4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:to="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_1ac51e0a-d238-4f50-bd37-640ac4da75d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_655d1335-2862-46d4-9557-0f28aa119f9a" xlink:to="loc_dei_DocumentDomain_1ac51e0a-d238-4f50-bd37-640ac4da75d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a64b81df-f216-4055-ac17-a2f6255277d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_6f4bcedd-8c61-459e-9f30-a75982fe1ae2" xlink:to="loc_dei_DocumentInformationLineItems_a64b81df-f216-4055-ac17-a2f6255277d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_60c448a6-5571-4833-a433-dce64c2d9072" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a64b81df-f216-4055-ac17-a2f6255277d9" xlink:to="loc_dei_DocumentType_60c448a6-5571-4833-a433-dce64c2d9072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c39fd4e-9690-494c-b476-bc07b2c6f3ff" xlink:to="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_1fe7855d-541a-4b5a-957a-3429fae924ec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_e312e63c-aa6e-48a5-b285-0eb65f852f7e" xlink:to="loc_dei_AddressTypeDomain_1fe7855d-541a-4b5a-957a-3429fae924ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_3679dcdc-42f3-424f-8ee3-75fcd865edeb" xlink:to="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ce47d4c6-fe8e-4c2f-9a3f-9189eec33ca0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressAddressLine1_ce47d4c6-fe8e-4c2f-9a3f-9189eec33ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_4ef1d7d1-c680-42e9-9934-498a89bcd3fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressAddressLine2_4ef1d7d1-c680-42e9-9934-498a89bcd3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d5781f82-c36b-48c9-bf94-8cb940533f23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressCityOrTown_d5781f82-c36b-48c9-bf94-8cb940533f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ae098984-7b9e-4ff0-9c02-7aeb03dbc392" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressStateOrProvince_ae098984-7b9e-4ff0-9c02-7aeb03dbc392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6dc18e75-7689-439b-9a17-b17cbce1e1a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_3d920389-ac8f-4d58-be28-049c2407dd0e" xlink:to="loc_dei_EntityAddressPostalZipCode_6dc18e75-7689-439b-9a17-b17cbce1e1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140393745013656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  04,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ANAPTYSBIO, INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-3828755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10770 Wateridge Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 210,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">362-6295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANAB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001370053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10770 Wateridge Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 210,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>anab-20220504_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="anab-20220504.xsd" xlink:type="simple"/>
    <context id="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001370053</identifier>
        </entity>
        <period>
            <startDate>2022-05-04</startDate>
            <endDate>2022-05-04</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV80L2ZyYWc6ZTg3NmQ4NTU2ODdkNDcyMDkwZDcxZjYxY2Y4Njk5Y2UvdGFibGU6NGM4YTgyNjZkMTMyNDA4ZGE5NTU3MjI4MzhiNGFlMmMvdGFibGVyYW5nZTo0YzhhODI2NmQxMzI0MDhkYTk1NTcyMjgzOGI0YWUyY18yLTEtMS0xLTM1OTQ5_afd22cf3-ad3f-4b3b-b8ee-ef90cda645b6">0001370053</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV80L2ZyYWc6ZTg3NmQ4NTU2ODdkNDcyMDkwZDcxZjYxY2Y4Njk5Y2UvdGFibGU6NGM4YTgyNjZkMTMyNDA4ZGE5NTU3MjI4MzhiNGFlMmMvdGFibGVyYW5nZTo0YzhhODI2NmQxMzI0MDhkYTk1NTcyMjgzOGI0YWUyY181LTEtMS0xLTM1OTQ5_6fd97710-5317-4a0b-9378-824dd9e66860">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY4_1bb7ceb0-f796-422e-a780-9299a1d85251">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xOTE_bb9275fd-aa25-439e-a7cf-ad34b17dd4d3">2022-05-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcy_4eeff25d-3b12-4deb-868f-caba772444e9">ANAPTYSBIO, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6YTczNWRjNWEzNzU0NGU5Zjg4MWI3NjJjM2I0ZWE4NGUvdGFibGVyYW5nZTphNzM1ZGM1YTM3NTQ0ZTlmODgxYjc2MmMzYjRlYTg0ZV8wLTAtMS0xLTM1OTQ5_e9e05957-dd2f-4f6c-b0e0-c6618c20a940">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6YTczNWRjNWEzNzU0NGU5Zjg4MWI3NjJjM2I0ZWE4NGUvdGFibGVyYW5nZTphNzM1ZGM1YTM3NTQ0ZTlmODgxYjc2MmMzYjRlYTg0ZV8wLTEtMS0xLTM1OTQ5_43e7e4e4-a598-4bea-8810-8bb9bff4c865">001-37985</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6YTczNWRjNWEzNzU0NGU5Zjg4MWI3NjJjM2I0ZWE4NGUvdGFibGVyYW5nZTphNzM1ZGM1YTM3NTQ0ZTlmODgxYjc2MmMzYjRlYTg0ZV8wLTItMS0xLTM1OTQ5_a576013f-c5c7-4385-9512-aadbc20e0409">20-3828755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcz_0dfee24b-7f04-4ffd-9995-e22cc8c511c7">10770 Wateridge Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzYz_2f3a8ca4-5293-49e5-942b-c14635aac315">Suite 210,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY5_80797694-da38-4665-a82a-8c2f955bf847">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzU4_38833837-9432-43b4-ae14-143bed20f4b5">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcw_a28e25e6-a905-4e71-bfd5-5a0df9b555a4">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzcx_3aab910d-5e2c-4eb6-a520-35730e1fbe3f">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzU5_79e1a37e-6ac0-4774-8261-ab995f03d47f">362-6295</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY0_bc0907ad-13c8-4430-a8ba-4d92770151d9">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzYx_3ef076ce-d39b-4a76-a3ea-9563edbb38d1">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzYy_45f8b98b-1621-4942-afdf-9b05e188a7b1">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY1_9297f29c-7910-430a-b680-38496ae4aefa">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6NDU4NTM4MjExZGNhNDA3ZTg4OGVlYTY2MzQ1NDhhOTQvdGFibGVyYW5nZTo0NTg1MzgyMTFkY2E0MDdlODg4ZWVhNjYzNDU0OGE5NF8xLTAtMS0xLTM1OTQ5_fb2e5091-1af4-490f-9a0f-ae89d9c552a3">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6NDU4NTM4MjExZGNhNDA3ZTg4OGVlYTY2MzQ1NDhhOTQvdGFibGVyYW5nZTo0NTg1MzgyMTFkY2E0MDdlODg4ZWVhNjYzNDU0OGE5NF8xLTEtMS0xLTM1OTQ5_35c3508d-d5e8-4fc1-b116-9d8ac2f29d62">ANAB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGFibGU6NDU4NTM4MjExZGNhNDA3ZTg4OGVlYTY2MzQ1NDhhOTQvdGFibGVyYW5nZTo0NTg1MzgyMTFkY2E0MDdlODg4ZWVhNjYzNDU0OGE5NF8xLTItMS0xLTM1OTQ5_ac5ed5ee-43a4-412f-a287-ff6615d1a36a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504"
      id="id3VybDovL2RvY3MudjEvZG9jOjc0ZDIxY2QwZmJjZDQwYWViOWI5MDRjODc4MWE4MDlhL3NlYzo3NGQyMWNkMGZiY2Q0MGFlYjliOTA0Yzg3ODFhODA5YV8xL2ZyYWc6NjFmMmJjNzY2NWU2NDdkZDhkNzdlNTg4NWExYTk1N2EvdGV4dHJlZ2lvbjo2MWYyYmM3NjY1ZTY0N2RkOGQ3N2U1ODg1YTFhOTU3YV8xNzY2_5d0800a5-7f56-4694-a095-df11dc4afb1e">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MQ]UZJOE9".GA,+]V)0^7$=13]\OED?[#]6K)2N?W<:/^%]G$F S(:@%QV3I
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ :8*D5!E%%?4W 0  )P(   \
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ :8*D5&60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( &F"I%1?QU P[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( &F"I%297)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ :8*D5/*2=GV[!   1Q4  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &F"I%2?H!OPL0(
M .(,   -              "  ?\,  !X;"]S='EL97,N>&UL4$L! A0#%
M  @ :8*D5)>*NQS     $P(   L              ( !VP\  %]R96QS+RYR
M96QS4$L! A0#%     @ :8*D5!E%%?4W 0  )P(   \              ( !
MQ!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &F"I%0D'INBK0   /@!
M   :              "  2@2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<U!+ 0(4 Q0    ( &F"I%1ED'F2&0$  ,\#   3              "  0T3
K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  %<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="anab-20220504.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anaptysbio.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="anab-20220504.htm">anab-20220504.htm</File>
    <File>anab-20220504.xsd</File>
    <File>anab-20220504_def.xml</File>
    <File>anab-20220504_lab.xml</File>
    <File>anab-20220504_pre.xml</File>
    <File>q12022earningsrelease.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "anab-20220504.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "anab-20220504_def.xml"
     ]
    },
    "inline": {
     "local": [
      "anab-20220504.htm"
     ]
    },
    "labelLink": {
     "local": [
      "anab-20220504_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "anab-20220504_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "anab-20220504.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 32,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "anab",
   "nsuri": "http://www.anaptysbio.com/20220504",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "anab-20220504.htm",
      "contextRef": "i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.anaptysbio.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "anab-20220504.htm",
      "contextRef": "i5869d5017ddd4f6191d5c3375f4df511_D20220504-20220504",
      "decimals": null,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]",
        "terseLabel": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]",
        "terseLabel": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]",
        "terseLabel": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]",
        "terseLabel": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.anaptysbio.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001370053-22-000031-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001370053-22-000031-xbrl.zip
M4$L#!!0    ( &F"I%1628XJLQ0  -)^   1    86YA8BTR,#(R,#4P-"YH
M=&WM/6MWVKBVW\^OT&7N/2==*P+);Y,V9V6 9)@)T":D&?(E2[9D<&(P8YL$
M\NOOEFR2 *%-VSS;S(=.0*^M_=Y;6^+]?Z?#"%V() WCT8<2+9,2^N_V^__!
M^._?#_91/?8G0S'*4"T1+!,<78;9 !USD9ZC((F'Z#A.SL,+AK$:4XO'LR3L
M#S*D$4U;:DRJ%G=]:GDZ9J;C8H,)'SNNS[#0'8,;CN>Z#M_L5W7-LRW'M[#M
M.PP;/'"QZQ""B>>X.M<<KOMDDU=M@VO4YR3P?&X0)CS7<XGA.[9#F4-<M>P@
M@]W!#D=IE8OP0VF09>-JI3+UDJB<"K_<CR\JT% !<.D_1JGH&DZO>UY>7I95
M[SCI0R^J5\)1%(Z$Q,Z\^Q2^.%\8<:FK_M1UW8IJ+;JN[R0!O9XO#>_JJ!%"
M*W^W]@_]@1@R'([2C(U\<3T*H S7P4TDW(O]PVEV=^^;#5:RA(W2($Z&+ /V
MD%@"*FB8:O-)5G:^N*9L]EAZ>TT,:%\8,2?#EY:E)B8.UJF:IQJQ4?]#28SP
MT6$)2"P8WWX_%!E#<E8L_IF$%Q]*M7B4 >/B[FP,R_OYIP^E3$RSBD)V9?M?
M__K7^RS,(K'-1LS#DF6)28SWE?S+]Y5\:B_FL^WW/+Q :3:+Q(<2#]-QQ&;5
M43P2 $ XK<J.(LG_##D7(_4GM+=!>I+0S]>?9@<B^% *3<=RN4FHS3DW HNZ
ME)N^KMMF +QN4GI:GX-R#5,)C=A0+BW":F,$\,UJL)V$1<T1%]._Q*R$0@Y3
M<_WSS*O'%_O:P45/;TWX6>/B9,\]ZYSYY*3>G/:T3Y<GPS_/3NJ?+GO'G\/.
M<=-LU0_..G7?:!TWC%8]&NSK[:AW%>OMO4^SUG'[O+5W$L(XTMK;C7IG4=CI
M[I#>55_OU'<'G?J.V?OLD'WM9-8[]JV3;E]O#S\9[>Z1UJGS\W;=G[7JYY<G
M=7]Z<M:#]7M&^^S<[&E'%WQO-_3VCJSV7LOH=?NS]MG)>:O;FK7K.\;)7L.$
M.?366=-H70W"-JS=&K:*,9]A+7-TTHT!C@' T-1@S6GKJDE:]<%YKWM.VUU8
M]ZQ_U=EKDM[QT:Q'G=E^MY&U#LETO]NBG>XG\Y0%7-/\ -01UP-L>+J'/4<(
M+ *7^)Q9ANE9I6T"8J?;A)CZ^\H"41^3QCN@=+E4O+L1Z[_1]FNTI2NTM0+N
MVC8EV-2I#::&>-C5;0<[FL&Y*RS+L4AI.V!1*E;(6ED4XT0$(A&@.=,[M(_4
M<-54:60@/%+*OIJ!SOE02L/A.)*J3WTW2"1?+"B:\C3E,$5E<8Y\_9M%"QC2
M>)*H3TK/5PMFRSGC>YAM/I%0VF3^*>3R<Q"*!"F Q)VJNM;\:U$NE@=OS[]:
MG'T,^(WY_!.8HR2K@U>Q+8'"!'2\,1]WTW8-)E_3==XR_SQ?I+* J#E6K]%8
MN:6V*Z#<<PVOT/DUQ^*4EFZ/*:S",!SA@9#.3]76QMG69<BS0942\G\EU6_[
M?3IFP%%>4H'1^=_Y)"M328 QB\+^J.H#!D52R@?/V_TXBI/J;T3]MQ7 #G'
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M\&B2NW=L6;<8$EC7G.'-9%UU(;]]*+'7'?(N'O6#R'$QGWIW6;2C3 A'&!-
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M3VQBH(D"+,$)C95)C.E=8MO3S]0DOPYN&ZS!"FRP1NN:#K13VS<7&$S8.(F
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M^.G%CUW$CP>+_Z.^3I=%SA=%57LB2#,C$PVXCNV4(J(<"&9_,)$D4<A"C&P
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MWDU#IKN(DQ+Z]DK%,2**NHB_%6C%&U/0 'MS_@L7"/:5:S_D4B:N_M,F7(Y
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MG,S#KG#'\&L0#KW/_P]02P$"% ,4    " !I@J145DF.*K,4  #2?@  $0
M            @ $     86YA8BTR,#(R,#4P-"YH=&U02P$"% ,4    " !I
M@J14##X@\H$"  "%"   $0              @ 'B%   86YA8BTR,#(R,#4P
M-"YX<V102P$"% ,4    " !I@J14B$UBWUX%  !5(P  %0
M@ &2%P  86YA8BTR,#(R,#4P-%]D968N>&UL4$L! A0#%     @ :8*D5 $!
M(9%@#0  [H$  !4              ( !(QT  &%N86(M,C R,C U,#1?;&%B
M+GAM;%!+ 0(4 Q0    ( &F"I%3;:UM&8 D  $91   5              "
M ;8J  !A;F%B+3(P,C(P-3 T7W!R92YX;6Q02P$"% ,4    " !I@J14WTSG
M8'L:  "\/P$ &0              @ %)-   <3$R,#(R96%R;FEN9W-R96QE
=87-E+FAT;5!+!08     !@ & (X!  #[3@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
